PHR vs PRVA Stock Comparison
Compare PHR and PRVA across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between PHR and PRVA?
PHR leads the current stock comparison as Phreesia, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Phreesia, Inc. vs Privia Health Group, Inc.
PHR leads
PHR leads by 5 AIQ points, primarily on Quality, but the lead has narrowed from 17 points over 30 sessions. Wall Street currently favors PRVA on target upside.
Fragile: 1 of 6 evidence groups support PHR, its lead is narrowing, and its current signal state is conflicted.
Phreesia, Inc.
Privia Health Group, Inc.
The Algovestiq AIQ Score currently favors PHR over PRVA, 44 versus 39 as of Sep 11, 2026. PHR's advantage is driven primarily by stronger quality, while PRVA holds the stronger risk resilience profile. PHR also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors PRVA. 1 of 6 covered evidence groups favor PHR today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 5 points. PHR lead: Weakening — the AIQ differential moved from 17 to 5 points over 30 sessions.
Compare Phreesia, Inc. and Privia Health Group, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare PHR and PRVA against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality59 vs 33PHR +26
- Risk Resilience49 vs 71PRVA +22
- Momentum24 vs 25Even
- Value42 vs 42Even
1 of 6 evidence groups favor PHR. PHR’s edge is concentrated in quality; PRVA keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
No factor moved materially.
No new signals fired.
No factor moved materially.
No new signals fired.
PHR's lead was unchanged in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — PHR and PRVA both carry a full feed there.
The central trade-off
PHR (Phreesia, Inc.): the stronger current systematic profile, led by quality.
PRVA (Privia Health Group, Inc.): the counter-case, on risk resilience, fundamentals, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PHRPHR on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
PRVAPRVA on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
EvenThe two are level on Momentum.
Lower downside
PRVAPRVA on Risk Resilience, by 22 points.
Analyst upside
PRVAPRVA on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors PHR, analyst targets favor PRVA. That disagreement is the most useful thing on this page.
| Measure | PHR | PRVA | Note |
|---|---|---|---|
| Implied upside to target | +15.3% | +33.8% | PRVA has more room |
| Target dispersion | +58.9% | +29.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 7 | 3 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
1 of 6 covered evidence groups favor PHR. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PHR | 44 vs 39 |
| Fundamentals | PRVAon balance | revenue growth 3% vs 4.8%; EPS growth 127.1% vs 183.4%; TTM ROE 2.8% vs 0%; gross margin 65.8% vs 7.6%; operating margin 0.7% vs 1.9% — PRVA takes 3 of 5 decided legs, not all of them |
| Valuation | Even | Value 42 vs 42 |
| Technicals | Even | Price vs 50-day -8.3% vs -13.5%; vs 200-day -16.4% vs -12.1% |
| Risk Resilience | PRVA | Risk Resilience 49 vs 71 |
| Analyst expectations | PRVA | Target upside 15.3% vs 33.8% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PHR and PRVA and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 5 points. (argues the conclusion is provisional)
- Only 1 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PHR.
How the comparison changed
119 daily snapshots · May 4 – Sep 10PHR lead: Weakening — the AIQ differential moved from 17 to 5 points over 30 sessions.
- Today
- PHR +5
- 44 vs 39
- 7 sessions ago
- PHR +7
- 46 vs 39
- 30 sessions ago
- PHR +17
- 55 vs 38
- 90 sessions ago
- PHR +3
- 56 vs 53
The lead changed hands 3 times in this window, most recently on Jun 26 when PHR moved ahead of PRVA.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 4 bearish / 2 neutral, conflicted
- Death Cross Active — bearish, trend, long horizon (8.19%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- BB Lower Band Breach — bullish, volatility, short horizon
3 bullish / 0 bearish / 1 neutral
- Golden Cross Active — bullish, trend, long horizon (1.78%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
PHR leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.38%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.25%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1PRVA closes the Quality gap — currently 26 points behind, the largest single contributor to PHR's edge.
- 2PRVA's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3PHR's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once.
- 4The narrowing continues — the lead has already given back 12 points over 30 sessions, and a further 5-point move would eliminate PHR's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
PRVA leads on balance| Metric | PHR | PRVA |
|---|---|---|
| Revenue growth (YoY) | 3% | 4.8% |
| EPS growth (YoY) | 127.1% | 183.4% |
| Gross margin | 65.8% | 7.6% |
| Operating margin | 0.7% | 1.9% |
| Return on equity (TTM) | 2.8% | 0% |
| Debt to equity | 0.26 | 0.01 |
Performance
PRVA leads 5 of 6 windows| Metric | PHR | PRVA |
|---|---|---|
| 1 week (5 sessions) | -14.2% | -1.7% |
| 1 month (20 sessions) | -17% | -5.4% |
| 3 months (63 sessions) | 11.3% | -11% |
| 6 months (126 sessions) | -10.3% | -7.7% |
| Year to date | -39.9% | -14.1% |
| 1 year (252 sessions) | -62% | -12.9% |
Technicals
Split| Metric | PHR | PRVA |
|---|---|---|
| RSI (14) | 25.3 | 28 |
| ADX (14) | 21.2 | 28.9 |
| Price vs 50-day | -8.3% | -13.5% |
| Price vs 200-day | -16.4% | -12.1% |
| Volatility (1M, annualized) | 49% | 16.1% |
Risk
PRVA is the more resilient| Metric | PHR | PRVA |
|---|---|---|
| Beta | 0.32 | 0.63 |
| Sharpe ratio | -1.39 | -0.4 |
| Sortino ratio | -1.51 | -0.65 |
| Max drawdown | -69.6% | -27.5% |
| Current drawdown | -61.7% | -27.5% |
| Annualized volatility | 58.7% | 32% |
| Value at risk (95%) | -5.3% | -3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, PHR or PRVA?
On the Algovestiq AIQ Score, PHR is the stronger of the two as of Sep 11, 2026, scoring 44 against PRVA's 39. The edge comes from quality. PRVA is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is PHR or PRVA the better buy right now?
PHR carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 1 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 5 points. Treat the lead as provisional.
Why does the AIQ Score favor PHR over PRVA?
The composite weights Quality, Value, Momentum and Risk Resilience. PHR leads Quality by 26 points; PRVA leads Risk Resilience by 22 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, PHR or PRVA?
Analyst price targets imply +15.3% upside for PHR and +33.8% for PRVA, so the Street currently favors PRVA. That points the opposite way to the AIQ Score, which favors PHR. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, PHR or PRVA?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, PHR or PRVA?
PRVA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, PHR or PRVA?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, PHR or PRVA?
PRVA is the more resilient of the two, so the other name carries the higher downside risk. PRVA on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is PHR more profitable than PRVA?
The profitability evidence is mixed: gross margin 65.8% vs 7.6%; operating margin 0.7% vs 1.9%; ttm roe 2.8% vs 0%. PHR leads on two measures and PRVA on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is PHR's lead over PRVA getting stronger or weaker?
PHR lead: Weakening — the AIQ differential moved from 17 to 5 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 3 times in that window, most recently on 2026-06-26, when PHR moved ahead of PRVA.
What would change the PHR vs PRVA verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PRVA closes the Quality gap — currently 26 points behind, the largest single contributor to PHR's edge; PRVA's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; PHR's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once; the narrowing continues — the lead has already given back 12 points over 30 sessions, and a further 5-point move would eliminate PHR's advantage entirely.
What do the current signals say about PHR and PRVA?
PHR: 2 bullish / 4 bearish / 2 neutral, conflicted. PRVA: 3 bullish / 0 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PHR is Death Cross Active (bearish, long horizon). On PRVA it is Golden Cross Active (bullish, long horizon).
Compare PHR and PRVA with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.